Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_assertion type Assertion NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_head.
- NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_assertion description "[These results point to IL-6 as an important mediator of bone loss in DMD and suggest that targeted anti-IL-6 therapy may have a positive impact on the bone phenotype in these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_provenance.
- NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_assertion evidence source_evidence_literature NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_provenance.
- NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_assertion SIO_000772 21509823 NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_provenance.
- NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_assertion wasDerivedFrom befree-2016 NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_provenance.
- NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_assertion wasGeneratedBy ECO_0000203 NP888813.RA7VHmSHRVfabbf4KrWoM6hTdlg9cHGRb9RpZBOpKhWlY130_provenance.